Status:
COMPLETED
Diabetes Prevention Program Lifestyle Intervention in the Marshallese Population
Lead Sponsor:
University of Arkansas
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will conduct a comparative effectiveness cluster-randomized controlled trial (cRCT) of two Diabetes Prevention Program (DPP) lifestyle interventions: a faith-based intervention (Whol...
Detailed Description
Background and Rationale Disparities in type 2 diabetes, pre-diabetes, and obesity among the Marshallese and Pacific Islanders. The Marshallese are a Pacific Islander population experiencing signifi...
Eligibility Criteria
Inclusion
- Self reported Marshallese
- 18 years of age or older
- BMI greater than or equal to 25
Exclusion
- A clinically significant medical condition likely to impact weight (cancer, HIV/AIDS, etc.)
- Currently pregnant or breastfeeding an infant who is 6 months old or younger
- Have any condition that makes it unlikely that the participant will be able to follow the protocol, such as terminal illness, plans to move out of the area within 6 months, an inability to finish the intervention, etc.
Key Trial Info
Start Date :
January 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 14 2020
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT03270436
Start Date
January 8 2018
End Date
May 14 2020
Last Update
December 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arkansas for Medical Sciences Northwest
Fayetteville, Arkansas, United States, 72703